lemonde.fr

WHO Approves New Mpox Vaccine

The World Health Organization approves a new mpox vaccine for emergency use, boosting global efforts to combat the ongoing outbreak.

Read original article in French

French

France

HealthSciencePublic HealthJapanGlobal HealthWhoVaccineMpoxEmergency Use AuthorizationKm Biologics

World Health Organization (Who)Km Biologics

Yukiko Nakatani

What is Japan's role in the distribution of this new vaccine?: Japan's government plans to provide the Democratic Republic of Congo (DRC) with 3.05 million doses of the LC16m8 vaccine.
How will this approval impact access to the mpox vaccine globally?: The approval aims to facilitate quicker access to vaccines in communities experiencing mpox outbreaks, as the WHO's emergency use authorization allows countries to swiftly approve and import the vaccine for distribution.
What is the significance of the WHO's approval of the LC16m8 mpox vaccine?: The World Health Organization (WHO) approved a new mpox vaccine, LC16m8, for emergency use, making it the second vaccine to receive WHO validation after MVA-BN.

Cognitive Concepts

2/5

Framing Bias

The article presents a positive framing of the vaccine approval, highlighting its potential benefits and downplaying any potential concerns.

1/5

Language Bias

The language used is generally neutral, but the emphasis on positive outcomes could be seen as subtly influencing the reader's perception.

3/5

Bias by Omission

The article focuses heavily on the positive aspects of the new vaccine's approval and its potential impact, while omitting potential drawbacks, limitations, or challenges related to vaccine distribution, efficacy, or safety.

Sustainable Development Goals

Good Health and Well-being Very Positive

Direct Relevance

The approval and distribution of a new mpox vaccine directly contributes to improving global health and well-being by providing a tool to control outbreaks and protect populations.

Jan 23, 01:10

Microplastics Linked to Brain Blood Clots, Raising Dementia and Stroke Risks

A Peking University study reveals microplastics in the brain trigger immune responses, causing blood clots that may lead to stroke, depression, and possibly dementia; further research is needed.

Jan 23, 01:10

Rare Gene Mutation Linked to Late-Onset Alzheimer's

A study of an Italian family with six members affected by late-onset Alzheimer's disease reveals a rare mutation in the GRIN2C gene as a probable cause, offering a significant advancement in understanding the disease's genetic basis.

Jan 22, 13:12

Surge in Four Viruses Strains US Healthcare Systems

Four viruses (influenza, COVID-19, RSV, and norovirus) are surging in the U.S., causing widespread illness and impacting healthcare systems, with the CDC reporting high positivity rates and increased hospital visits; vaccines are available for some, but not all, of the viruses.

Jan 22, 04:12

Physical Fitness Linked to Lower Cancer Mortality Risk

A study of nearly 47,000 cancer patients found that muscular strength and cardiorespiratory fitness were associated with a 31–46% lower risk of death from any cause, with even greater reductions in specific cancer types and stages; this research, published in the British Journal of Sports Medicine, suggests tailored exercise plans may improve survival rates.